113 related articles for article (PubMed ID: 20215562)
1. A molecular model of the human UDP-glucuronosyltransferase 1A1, its membrane orientation, and the interactions between different parts of the enzyme.
Laakkonen L; Finel M
Mol Pharmacol; 2010 Jun; 77(6):931-9. PubMed ID: 20215562
[TBL] [Abstract][Full Text] [Related]
2. The human UDP-glucuronosyltransferase: identification of key residues within the nucleotide-sugar binding site.
Patana AS; Kurkela M; Goldman A; Finel M
Mol Pharmacol; 2007 Sep; 72(3):604-11. PubMed ID: 17578897
[TBL] [Abstract][Full Text] [Related]
3. Protein-protein interactions between the bilirubin-conjugating UDP-glucuronosyltransferase UGT1A1 and its shorter isoform 2 regulatory partner derived from alternative splicing.
Rouleau M; Collin P; Bellemare J; Harvey M; Guillemette C
Biochem J; 2013 Feb; 450(1):107-14. PubMed ID: 23148825
[TBL] [Abstract][Full Text] [Related]
4. Role of cysteine residues in the function of human UDP glucuronosyltransferase isoform 1A1 (UGT1A1).
Ghosh SS; Lu Y; Lee SW; Wang X; Guha C; Roy-Chowdhury J; Roy-Chowdhury N
Biochem J; 2005 Dec; 392(Pt 3):685-92. PubMed ID: 16171463
[TBL] [Abstract][Full Text] [Related]
5. Influence of N-terminal domain histidine and proline residues on the substrate selectivities of human UDP-glucuronosyltransferase 1A1, 1A6, 1A9, 2B7, and 2B10.
Kerdpin O; Mackenzie PI; Bowalgaha K; Finel M; Miners JO
Drug Metab Dispos; 2009 Sep; 37(9):1948-55. PubMed ID: 19487247
[TBL] [Abstract][Full Text] [Related]
6. The first aspartic acid of the DQxD motif for human UDP-glucuronosyltransferase 1A10 interacts with UDP-glucuronic acid during catalysis.
Xiong Y; Patana AS; Miley MJ; Zielinska AK; Bratton SM; Miller GP; Goldman A; Finel M; Redinbo MR; Radominska-Pandya A
Drug Metab Dispos; 2008 Mar; 36(3):517-22. PubMed ID: 18048489
[TBL] [Abstract][Full Text] [Related]
7. Ligand orientation governs conjugation capacity of UDP-glucuronosyltransferase 1A1.
Takaoka Y; Ohta M; Takeuchi A; Miura K; Matsuo M; Sakaeda T; Sugano A; Nishio H
J Biochem; 2010 Jul; 148(1):25-8. PubMed ID: 20435641
[TBL] [Abstract][Full Text] [Related]
8. Influence of mutations associated with Gilbert and Crigler-Najjar type II syndromes on the glucuronidation kinetics of bilirubin and other UDP-glucuronosyltransferase 1A substrates.
Udomuksorn W; Elliot DJ; Lewis BC; Mackenzie PI; Yoovathaworn K; Miners JO
Pharmacogenet Genomics; 2007 Dec; 17(12):1017-29. PubMed ID: 18004206
[TBL] [Abstract][Full Text] [Related]
9. Amino terminal domains of human UDP-glucuronosyltransferases (UGT) 2B7 and 2B15 associated with substrate selectivity and autoactivation.
Lewis BC; Mackenzie PI; Elliot DJ; Burchell B; Bhasker CR; Miners JO
Biochem Pharmacol; 2007 May; 73(9):1463-73. PubMed ID: 17223084
[TBL] [Abstract][Full Text] [Related]
10. How many and which amino acids are responsible for the large activity differences between the highly homologous UDP-glucuronosyltransferases (UGT) 1A9 and UGT1A10?
Itäaho K; Laakkonen L; Finel M
Drug Metab Dispos; 2010 Apr; 38(4):687-96. PubMed ID: 20089735
[TBL] [Abstract][Full Text] [Related]
11. Mutational analysis of the carboxy-terminal region of UDP-glucuronosyltransferase 2B1.
Meech R; Yogalingam G; Mackenzie PI
DNA Cell Biol; 1996 Jun; 15(6):489-94. PubMed ID: 8672245
[TBL] [Abstract][Full Text] [Related]
12. Insights on membrane topology and structure/function of UDP-glucuronosyltransferases.
Magdalou J; Fournel-Gigleux S; Ouzzine M
Drug Metab Rev; 2010 Feb; 42(1):159-66. PubMed ID: 19807219
[TBL] [Abstract][Full Text] [Related]
13. Homodimerization of UDP-glucuronosyltransferase 2B7 (UGT2B7) and identification of a putative dimerization domain by protein homology modeling.
Lewis BC; Mackenzie PI; Miners JO
Biochem Pharmacol; 2011 Dec; 82(12):2016-23. PubMed ID: 21930117
[TBL] [Abstract][Full Text] [Related]
14. Cloning and stable expression of a cDNA encoding a rat liver UDP-glucuronosyltransferase (UDP-glucuronosyltransferase 1.1) that catalyzes the glucuronidation of opioids and bilirubin.
Coffman BL; Green MD; King CD; Tephly TR
Mol Pharmacol; 1995 Jun; 47(6):1101-5. PubMed ID: 7603447
[TBL] [Abstract][Full Text] [Related]
15. Crystal structure of the cofactor-binding domain of the human phase II drug-metabolism enzyme UDP-glucuronosyltransferase 2B7.
Miley MJ; Zielinska AK; Keenan JE; Bratton SM; Radominska-Pandya A; Redinbo MR
J Mol Biol; 2007 Jun; 369(2):498-511. PubMed ID: 17442341
[TBL] [Abstract][Full Text] [Related]
16. Comparative modelling of the human UDP-glucuronosyltransferases: insights into structure and mechanism.
Locuson CW; Tracy TS
Xenobiotica; 2007 Feb; 37(2):155-68. PubMed ID: 17484518
[TBL] [Abstract][Full Text] [Related]
17. Determinants of UDP glucuronosyltransferase membrane association and residency in the endoplasmic reticulum.
Meech R; Mackenzie PI
Arch Biochem Biophys; 1998 Aug; 356(1):77-85. PubMed ID: 9681994
[TBL] [Abstract][Full Text] [Related]
18. Photoaffinity labeling of the aglycon binding site of the recombinant human liver UDP-glucuronosyltransferase UGT1A6 with 7-azido-4-methylcoumarin.
Senay C; Battaglia E; Chen G; Breton R; Fournel-Gigleux S; Magdalou J; Radominska-Pandya A
Arch Biochem Biophys; 1999 Aug; 368(1):75-84. PubMed ID: 10415114
[TBL] [Abstract][Full Text] [Related]
19. Glucuronidation of antiallergic drug, Tranilast: identification of human UDP-glucuronosyltransferase isoforms and effect of its phase I metabolite.
Katoh M; Matsui T; Yokoi T
Drug Metab Dispos; 2007 Apr; 35(4):583-9. PubMed ID: 17220234
[TBL] [Abstract][Full Text] [Related]
20. The interactions between the N-terminal and C-terminal domains of the human UDP-glucuronosyltransferases are partly isoform-specific, and may involve both monomers.
Kurkela M; Hirvonen J; Kostiainen R; Finel M
Biochem Pharmacol; 2004 Dec; 68(12):2443-50. PubMed ID: 15548391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
